Pharmacological Inhibition of Inositol Hexakisphosphate Kinase 1 Protects Mice against Obesity-Induced Bone Loss

Obesity and type II diabetes mellitus (T2DM) are prominent risk factors for secondary osteoporosis due to the negative impacts of hyperglycemia and excessive body fat on bone metabolism. While the armamentarium of anti-diabetic drugs is expanding, their negative or unknown impacts on bone metabolism...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Siddaraju V. Boregowda, Manjunatha K. Nanjappa, Cori N. Booker, Jacqueline Strivelli, Valentina M. Supper, Paul S. Cooke, Donald G. Phinney
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-08-01
Serie:	Biology
Soggetti:	diet high fat obesity osteoporosis anti-obesity drugs inositol hexakisphosphate kinase 1
Accesso online:	https://www.mdpi.com/2079-7737/11/9/1257
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!